"Normal" blood glucose and coronary risk

doi:10.1136/bmj.322.7277.5

BMJ 2001;322:5-6 ( 6 January )

Editorials

"Normal" blood glucose and coronary risk

Dose response effect seems consistent throughout the glycaemic continuum

Papers p 15

The first 150 words of the full text of this article appear below.

Although diabetes is a strong risk factor for coronary heart disease, the association between glycaemia within the "normalrange" and coronary heart disease has been somewhat controversial.¹A 1979 collaborative report from 15 countries found the risk ratioin the highest versus the lowest centile of glycaemia to rangefrom 0.34 to 6.07 in men from Finland, Denmark, France, the UnitedKingdom, and the United States.² In other cohort studies, includingWhitehall³ and Framingham,⁴ there appeared to be a thresholdeffect, with risk observed only at glucose levels approachingor including current diagnostic criteria for diabetes. There areseveral possible reasons for these contradictory results, including:the failure to exclude people with diabetes from the cohorts,compatible with a threshold effect; the multifactorial aetiologyof coronary heart disease, compatible with confounding; or thelarge intra-individual variation in glucose (especially postchallengeglucose) values, compatible with misclassificationbias.

Glycosylated haemoglobin, an integrated estimate of glucose over . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

C reactive protein and acute phase of ischaemic stroke: Mario Di Napoli
BMJ 2001 322: 1605. [Extract] [Full Text]

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk): Kay-Tee Khaw, Nicholas Wareham, Robert Luben, Sheila Bingham, Suzy Oakes, Ailsa Welch, and Nicholas Day
BMJ 2001 322: 15. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

John, W G., Noonan, K., Mannan, N., Boucher, B. J (2005). Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am. J. Clin. Nutr. 82: 517-522 [Abstract] [Full text]
O'Connor, P. J. (2003). Setting evidence-based priorities for diabetes care improvement. Int J Qual Health Care 15: 283-285 [Full text]
Jesudason, D. R., Dunstan, K., Leong, D., Wittert, G. A. (2003). Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes: Implications for the use of FPG and HbA1c for cost-effective screening. Diabetes Care 26: 485-490 [Abstract] [Full text]
Timms, P.M., Mannan, N., Hitman, G.A., Noonan, K., Mills, P.G., Syndercombe-court, D., Aganna, E., Price, C.P., Boucher, B.J. (2002). Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM 95: 787-796 [Abstract] [Full text]
Davidson, M. B. (2002). Counterpoint: The Oral Glucose Tolerance Test Is Superfluous. Diabetes Care 25: 1883-1885 [Full text]
Williams, K. J. (2002). Editorial: The Mystery--and Importance--of Diabetic Atherosclerotic Vascular Disease. J. Clin. Endocrinol. Metab. 87: 33-34 [Full text]
Di Napoli, M. (2001). C reactive protein and acute phase of ischaemic stroke. BMJ 322: 1605-1605 [Full text]
Jarrett, R J, Lamb, E., Khaw, K.-T., Wareham, N., Vlassov, V. (2001). Glycated haemoglobin, diabetes, and mortality in men. BMJ 322: 996-996 [Full text]
Pearson, J., Bergenstal, R. (2001). Fine-Tuning Control: Pattern Management Versus Supplementation: View 1: Pattern Management: an Essential Component of Effective Insulin Management. Diabetes Spectr. 14: 75-78 [Abstract] [Full text]